We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Siegel - Vantage 095: Vorinostat in Combination with Bortezomib in Salvage Multiple Myeloma Patients: Final Study Results of a Global Phase 2b Trial
David S. Siegel, MD, PhD
Hackensack University Medical Center
Hackensack, New Jersey, USA
12.07.11

Be the first to comment

 related articles